Comparison of two polymorphisms of the interleukin-1 gene family
- 1 July 1999
- journal article
- Published by Wolters Kluwer Health in Critical Care Medicine
- Vol. 27 (7) , 1330-1334
- https://doi.org/10.1097/00003246-199907000-00024
Abstract
To determine whether the allele frequencies and genotype distribution of an interleukin (IL)-1beta TaqI polymorphism and an interleukin-1 receptor antagonist polymorphism are associated with susceptibility to and outcome of severe sepsis. In addition, we analyze a possible linkage disequilibrium between a previously described NcoI polymorphism within the tumor necrosis factor (TNF) locus and the two IL-1 gene family polymorphisms. Prospective, consecutive entry study of patients with diagnosis of severe sepsis. Intensive care unit (ICU) of a university hospital. Ninety-three patients with diagnosis of severe sepsis admitted to the ICU between June 1993 and June 1996. None. The polymorphic region within intron 2 of the IL-1ra gene containing variable numbers of a tandem repeat of 86 base pairs was amplified by means of the polymerase chain reaction. Alleles A1-5 are identified according to the size of the amplified DNA product. The region that contains the biallelic TaqI site within exon 5 of the IL-1beta gene was analyzed by polymerase chain reaction amplification and subsequent digestion using the TaqI restriction enzyme. A NcoI TNF-beta polymorphism was determined. The allele frequency of the allele IL-1raA2 was increased in 93 patients with severe sepsis compared with normal individuals (p < .01). No association with patients' outcome was observed. Allele frequencies or genotype distribution of the IL-1beta TaqI polymorphism did not differ between patients and controls. In addition, the allele TNFB2 of the NcoI TNF-beta polymorphism was associated with nonsurvival. Occurrence of the TNFB1 and TNFB2 alleles and genotypes was unrelated to alleles and genotypes of the two IL-1 gene family polymorphisms. In contrast to the TNF-beta NcoI polymorphism, which has been associated with patients' nonsurvival, the allele IL-1raA2 of the polymorphism within the intron 2 of IL-1ra may contribute to susceptibility to sepsis.Keywords
This publication has 25 references indexed in Scilit:
- A genomic polymorphism within the tumor necrosis factor locus influences plasma tumor necrosis factor-alpha concentrations and outcome of patients with severe sepsisCritical Care Medicine, 1996
- Human tumor necrosis factor receptor (p55) and interleukin 10 gene transfer in the mouse reduces mortality to lethal endotoxemia and also attenuates local inflammatory responses.The Journal of Experimental Medicine, 1995
- An Allele of the Interleukin-1 Receptor Antagonist as a Genetic Severity Factor in Alopecia AreataJournal of Investigative Dermatology, 1995
- Increased Plasma Concentrations of Interleukin-1 Receptor Antagonist in Neonatal SepsisPediatric Research, 1995
- Interleukin 1 receptor antagonist gene polymorphism association with lichen sclerosusHuman Genetics, 1994
- Novel genetic association between ulcerative colitis and the anti-inflammatory cytokine interleukin-1 receptor antagonistGastroenterology, 1994
- Polymorphism in human IL-1 receptor antagonist gene intron 2 is caused by variable numbers of an 86-bp tandem repeatHuman Genetics, 1993
- A Taql polymorphism in the human interleukin‐1β (IL‐1β) gene correlates with IL‐1β secretion in vitroEuropean Journal of Clinical Investigation, 1992
- Extensive genetic polymorphism in the human tumor necrosis factor region and relation to extended HLA haplotypes.Proceedings of the National Academy of Sciences, 1991
- Multiple-Organ FailureArchives of Surgery, 1985